Pfizer Inc

Change company Symbol lookup

Select an option...

PFE Pfizer Inc

PFC Premier Financial Corp (OHIO)

TWTR Twitter Inc

BCEI Bonanza Creek Energy Inc

RNGR Ranger Energy Services Inc

$RFTREES Refinitiv Eurozone ESG Select Index

BAC Bank of America Corp

DIS Walt Disney Co

AAPL Apple Inc

MCD McDonald's Corp

Go

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for XALKORI(R) (crizotinib) for the treatment of pediatric patients 1 year of age and older and young...(BusinessWire)

The global opioid use disorder market is expected to experience exponential growth by reaching USD 4.87 billion by 2027 while exhibiting a CAGR of 8.7% between 2020 and 2027. The growth is attributable to the increasing focus by the government...(Globe Newswire)

With availability of limited preventive or therapeutic interventions for respiratory viruses resulting in morbidity and mortality globally, there is significant increase in investments through authoritative bodies for research and development...(Globe Newswire)

InvestorsObserver issues critical PriceWatch Alerts for PLUG, PFE, CCL, AAL, and BILI. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to...(BusinessWire)

Vedanta Biosciences, a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human microbiome-derived bacteria, today announced that Pfizer Inc. (NYSE: PFE) has...(BusinessWire)

--New investments include companies focused on Oncology, Rare Disease, and Inflammation & Immunology Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech...(BusinessWire)

CureDuchenne, a leading global nonprofit dedicated to finding and funding a cure for Duchenne muscular dystrophy (DMD), celebrates Pfizer Inc's (NYSE: PFE) announcement surrounding the first dosing of a patient with Duchenne in their Phase III gene...(BusinessWire)

InvestorsObserver issues critical PriceWatch Alerts for NIO, PLUG, PFE, SRNE, and BNTX. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

New York und Mainz, Deutschland 08. Januar 2021 -- Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute Ergebnisse einer in vitro-Studie bekannt, die zeigen, dass Personen, die den Pfizer-BioNTech-COVID-19-Impfstoff erhalten haben...(Thomson Reuters ONE)

New York and Mainz, Germany, January 8, 2021 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies...(Thomson Reuters ONE)

InvestorsObserver issues critical PriceWatch Alerts for PFE, TSLA, GM, JPM, and UNH. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 CIFFREO study, which will evaluate the efficacy and safety of investigational gene therapy candidate PF-06939926 in boys with Duchenne muscular...(BusinessWire)

ImaginAb Inc., a leading global provider of immuno-oncology imaging agents, today announced it has signed a new multi-year, non-exclusive license with Pfizer Inc. (NYSE: PFE) to supply 89Zr CD8 Immuno-PET agent, which can be used to image CD8 T...(PR Newswire)

InvestorsObserver issues critical PriceWatch Alerts for C, PFE, CLSK, FCEL, and BP. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

Dewpoint Therapeutics, the biomolecular condensates company, today announced a new research collaboration with Pfizer (NYSE: PFE) for the development of potential therapeutics for the treatment of myotonic dystrophy type 1, DM1, a rare genetic...(PR Newswire)

InvestorsObserver issues critical PriceWatch Alerts for PFE, TSLA, GS, CAT, and WMT. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to two webcasts of discussions with Pfizer leadership at the 39th Annual J.P. Morgan Healthcare Conference to be held virtually. (BusinessWire)

InvestorsObserver issues critical PriceWatch Alerts for NIO, PFE, CLSK, ROKU, and AAPL. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food and Drug Administration (FDA) has accepted for filing the initial Biologics License Application (BLA) for somatrogon, a long-acting human growth hormone that...(BusinessWire)